Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation

Cancer Research

Volumn 64, Issue 23, 2004, Pages 8613-8619

  Im, Jae Hong ^a   Fu, Weili ^a   Wang, Hui ^a   Bhatia, Sujata K ^b   Hammer, Daniel A ^b   Kowalska, M Anna ^a   Muschel, Ruth J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN; GREEN FLUORESCENT PROTEIN; HIRUDIN; PADGEM PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CANCER CELL CULTURE; CELL INTERACTION; CELL SPREADING; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; LUNG BLOOD VESSEL; METASTASIS; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTE; TUMOR CELL;

ADENOCARCINOMA; ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CELL COMMUNICATION; CELL LINE, TUMOR; COLONIC NEOPLASMS; FIBRINOGEN; FIBROSARCOMA; HIRUDINS; HUMANS; LUNG; LUNG NEOPLASMS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASMS; RATS; THROMBIN;

EID: 9244265563     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2078     Document Type: Article

References (47)

1. Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 2003;22:6524-36.
2. Honn KV, Tang DC, Crissman JD. Platelets and cancer metastasis: a casual relationship? Cancer Metastasis Rev 1992;11:325-51.
3. Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 1968;61:46-52.
4. Hejna M, Raderer M, Zielinski CC. Inhibition of metastases by anticoagulants. J Natl Cancer Inst (Bethesda) 1999;91:22-36.
5. Amirkhosravi A, Mousa SA, Amaya M, et al. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost 2003;90:549-54.
6. Honn KV, Tang DG, Grossi IM, et al. Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. Exp Cell Res 1994;210:1-9.
7. Camerer E, Qazi AA, Duong DN, et al. Platelets, protease-activated receptors and fibrinogen in hematogenous metastasis. Blood 2004;104:397-401.
8. Bakewell SJ, Nestor P, Prasad S, et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proc Natl Acad Sci USA 2003;100:14205-10.
9. Beviglia L, Stewart GJ, Niewiarowski S. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Oncol Res 1995;7:7-20.
10. Sindelar WF, Tralka TS, Ketcham AS. Electron microscopic observation on formation of pulmonary metastases. J Surg Res 1975;18:137-61.
11. Crissman JD, Hatfield JS, Menter DG, Sloane B, Honn KV. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 1988;48:4065-72.
12. Tirnar J, Ladányi A, Peták I, Jeney A, Kopper L. Molecular pathology of tumor metastasis III: target and combinational therapies. Pathol Oncol Res 2003;9:49-72.
13. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance D. Interaction between cancer cells and the endothelium in metastasis. J Pathol 2000;190:310-29.
14. Steinert BW, Tang DG, Grossi IM, Umbarger LA, Honn KV. Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation. Int J Cancer 1993;54:92-101.
15. Varki NM, Varki A. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans. Semin Thromb Hemost 2002;28:53-66.
16. Colucci M, Delaini F, de Bellis Vitti G, et al. Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells: role of vitamin K deficiency. Biochem Pharmacol 1983;32:1689-91.
17. Iwakawa A, Gasic TB, Viner AD, Gasic GJ. Promotion of lung tumor colonization in mice by the synthetic thrombin inhibitor (no. 805) and its reversal by leech salivary gland extracts. Clin Exp Metastasis 1986;4:205-20.
18. Esumi N, Fan D, Filder IJ. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res 1991;51:4549-56.
19. Palumbo JS, Potter JM, Kaplan LS, et al. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 2002;62:6966-72.
20. Palumbo JS, Kombrinck KW, Drew AF, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000;96:3302-9.
21. Ossowski L, Aguirre-Ghiso JA. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 2000;12:613-20.
22. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995;92:8205-9.
23. Amirkhosravi A, Meyer T, Chang JY, et al. Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost 2002;87:930-6.
24. Nierodzik ML, Chen K, Takeshita K, et al. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 1998;92:3694-700.
25. Nierodzik ML, Klepfish A, Karpatkin S. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 1995;74:282-90.
26. Nierodzik ML, Kajumo F, Karpatkin S. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 1992;52:3267-72.
27. Al-Medhi AB, Tozawa K, Fisher AB, et al. Intravascular origin of metastasis from the proliferation of endothelium attached tumor cells: a new model for metastasis. Nat Med 2000;6:100-2.
28. Al-Mehdi AB, Zhao G, Dodia C, et al. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res 1998;83:730-7.
29. Wang H, Fu W, Im JH, et al. Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 2004;164:935-41.
30. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002;8:1175-80.
31. Aigner A, Fischer D, Merdan T, et al. Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Ther 2002;9:1700-7.
32. Hosaka Y, Higuchi T, Tsumagari M, Ishii H. Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin. Cancer Lett 2000;161:231-40.
33. Volpert OV, Lawler J, Bouck NP. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastasis via thrombospondin-1. Proc Natl Acad Sci USA 1998;95:6343-8.
34. Hua J, Muschel RJ. Inhibition of matrix metalloproteinase 9 expression by a ryibozyme blocks metastasis in a rat sarcoma model system. Cancer Res 1996;56:5279-84.
35. McCool DJ, Okada Y, Frostner JF, Frostner GG. Roles of calreticulin and calnexin during musin synthesis in LS180 and HT29/A1 human colonic adenocarcinoma cells. Biochem J. 1999;341:593-600.
36. Satyamoorthy K, DeJesus E, Linnenbach AJ, et al. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res 1997;7:S35-42.
37. Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996;93:11877-82.
38. Eslin DE, Zhang C, Samuels KJ, et al. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood. In press 2004.
39. Usami S, Chen HH, Zhao Y, Chien S, Skalak R. Design and construction of a linear shear stress flow chamber. Ann Biomed Eng 1993;21:77-83.
40. x-mediated, PSGL-1-independent rolling adhesion on P-selectin. Biophys J 2000;79:694-706.
41. Rand ML, Wang H, Mody M, et al. Concurrent measurement of the survival of two populations of rabbit platelets labeled with either two PKH lipophilic dyes or two concentrations of biotin. Cytometry 2002;47:111-7.
42. Kim YJ, Boris L, Varki NM, Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 1998;95:9325-30.
43. Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999;59:1295-300.
44. Amirkhosravi M, Francis JL. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation. Thromb Haemost 1995;73:59-65.
45. Verheul HM, Jorna AS, Hoekman K, et al. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 2000;96:4216-21.
46. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
47. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 2003;3:411-21.